Stem cell transplantation for the treatment of myocardial infarction.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Transplant Immunology

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TRIM.2005.09.004PMID 16412954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

  2005cited by this paper
• Unchain my heart: the scientific foundations of cardiac repair.

  2005cited by this paper
• Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.

  2005cited by this paper
• Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

  2005cited by this paper
• Efectos de la movilización de células madre mediante el uso de factor estimulante de colonias granulocíticas en pacientes con infarto agudo de miocardio anterior revascularizado percutáneamente

  2005cited by this paper
• Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction

  2005cited by this paper
• Comments about possible use of human embryonic stem cell-derived cardiomyocytes to direct autologous adult stem cells into the cardiomyogenic lineage

  2005cited by this paper
• [Effects of stem-cell mobilization with recombinant human granulocyte colony stimulating factor in patients with percutaneously revascularized acute anterior myocardial infarction].

  2005cited by this paper
• Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.

  2005cited by this paper
• Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

  2005cited by this paper
• Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid-mediated stromal-cell-derived factor-1α treatment

  2005cited by this paper
• Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.

  2005cited by this paper
• Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment.

  2005cited by this paper
• Regeneration of Infarcted Myocardium by Intramyocardial Implantation of Ex Vivo Transforming Growth Factor-&bgr;–Preprogrammed Bone Marrow Stem Cells

  2005cited by this paper
• Repair of Infarcted Myocardium Mediated by Transplanted Bone Marrow–Derived CD34+ Stem Cells in a Nonhuman Primate Model

  2005cited by this paper
• Bone marrow cell transplantation in clinical perspective.

  2005cited by this paper
• Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass.

  2005cited by this paper
• Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy.

  2005cited by this paper
• Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function.

  2005cited by this paper
• Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects

  2005cited by this paper
• Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.

  2005cited by this paper
• Clinical applications of stem cells for the heart.

  2005cited by this paper
• Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction

  2004cited by this paper
• Both Cell Fusion and Transdifferentiation Account for the Transformation of Human Peripheral Blood CD34-Positive Cells Into Cardiomyocytes In Vivo

  2004cited by this paper
• In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease

  2004cited by this paper
• Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.

  2004cited by this paper
• Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

  2004cited by this paper
• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

  2004cited by this paper
• Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration.

  2004cited by this paper
• Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase

  2004cited by this paper
• Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

  2004cited by this paper
• Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction

  2004cited by this paper
• Stem cell therapy for the heart.

  2004cited by this paper
• Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization

  2004cited by this paper
• Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction.

  2004cited by this paper
• Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation

  2004cited by this paper
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

  2004cited by this paper
• Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium.

  2004cited by this paper
• Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

  2004cited by this paper
• Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro.

  2004cited by this paper
• Autologous stem cell transplantation for myocardial repair.

  2004cited by this paper
• Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.

  2004cited by this paper
• Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling

  2003cited by this paper
• Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.

  2003cited by this paper
• Transplantation of Autologous Fresh Bone Marrow Into Infarcted Myocardium: A Word of Caution

  2003cited by this paper
• Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells

  2003cited by this paper
• Adult stem cell therapy in perspective.

  2003cited by this paper
• Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

  2003cited by this paper
• Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

  2003cited by this paper
• Treatment of acute myocardial infarction: better, but still not good enough.

  2003cited by this paper
• Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure?

  2003cited by this paper
• Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

  2003cited by this paper
• Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice.

  2003cited by this paper
• Chimerism of the transplanted heart.

  2002cited by this paper
• Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting.

  2002cited by this paper
• Myocyte growth and cardiac repair.

  2002cited by this paper
• Adult-derived stem cells from the liver become myocytes in the heart in vivo.

  2001cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Evidence that human cardiac myocytes divide after myocardial infarction.

  2001cited by this paper
• Cell Transplantation—A Potential Therapy for Cardiac Repair in the Future?

  2001cited by this paper
• Autologous transplantation of bone marrow cells improves damaged heart function.

  1999cited by this paper
• Myocyte proliferation in end-stage cardiac failure in humans.

  1998cited by this paper
• Gene transfer and cell transplant: an experimental approach to repair a 'broken heart'.

  1997cited by this paper
• Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD.

  1996cited by this paper
• Left ventricular remodeling after acute myocardial infarction.

  1995cited by this paper
• Movement of necrotic wavefront after coronary artery occlusion in rabbit.

  1982cited by this paper

• Cardiovascular Therapeutic Applications of the Human Amnion: Membrane, Cells, and Beyond

  2025cites this paper
• Does the conditioned medium trigger the adipose-derived mesenchymal stem cells differentiation into Chondrocytes?

  2018cites this paper
• Cardiac stem cell transplantation with 2,3,5,4'-tetrahydroxystilbehe-2-O-β-d-glucoside improves cardiac function in rat myocardial infarction model.

  2016cites this paper
• Dental pulp stem cells: function, isolation and applications in regenerative medicine

  2015cites this paper
• Application of dental stem cells in regenerative medicine

  2015cites this paper
• Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction.

  2013cites this paper
• Does aging of mesenchymal stem cells limit their potential application in clinical practice?

  2013cites this paper
• Wykorzystanie medycyny regeneracyjnej w leczeniu wybranych chorób skóry

  2013cites this paper
• Human Umbilical Cord Blood for Transplantation Therapy in Myocardial

  2013cites this paper
• Experience from Experimental Cell Transplantation Therapy of Myocardial Infarction: What have we Learned?

  2013cites this paper
• Does aging of mesenchymal stem cells limit their potential application in clinical practice?

  2012cites this paper
• Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease

  2012cites this paper
• Studies on bone marrow-derived stem cells in patients with acute myocardial infarction

  2011cites this paper
• Bone marrow-derived stem cell therapy in acute myocardial infarction : an experimental porcine model

  2011cites this paper
• Nanoparticle-based monitoring of cell therapy

  2011cites this paper
• [Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration].

  2011cites this paper
• In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage

  2010cites this paper
• Experimental cell transplantation therapy in rat myocardial infarction model including nude rat preparation.

  2010cites this paper
• Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: strain rate imaging in a model of hibernating myocardium.

  2009cites this paper
• Applications of Nanomaterials in Cell Stem Therapies and the Onset of Nanomedicine

  2009cites this paper
• Cardiac recovery by stem and progenitor cells

  2009cites this paper
• Stem Cell Transplantation Therapy for Heart Disease

  2009cites this paper
• Mesenchymal stromal cells: tissue engineers and immune response modulators

  2008cites this paper
• Transplantation of human umbilical cord blood cells for the repair of myocardial infarction.

  2008cites this paper
• 5‐Azacytidine‐treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies

  2008cites this paper
• Intramyocardial transplantation of bone marrow-derived stem cells: ultrasonic strain rate imaging in a model of hibernating myocardium.

  2008cites this paper
• Ischemic cardiomyopathy: Pathological Findings In A Case Of Stem Cell Implantation

  2008cites this paper
• Cell Transplantation Therapy for Myocardial Repair: Current Status and Future Challenges

  2008cites this paper
• Myocardial regeneration by human amniotic fluid stem cells: challenges to be overcome.

  2007cites this paper
• Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats.

  2007cites this paper
• Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct.

  2007cites this paper
• Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts.

  2007cites this paper
• 14 – Myocardial regeneration, tissue engineering and therapy

  2007cites this paper
• Stem cell therapy after myocardial infarction: ready for clinical application?

  2006cites this paper
• Heart repair and stem cells

  2006cites this paper